Dr. Neeta Pandit-Taskar, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Renal Cell Carcinoma
Studies Pancreatic Cancer
10 reported clinical trials
13 drugs studied
Area of expertise
1Renal Cell Carcinoma
Stage IV
KRAS positive
2Pancreatic Cancer
CA19-9 positive
CA19-9 negative
Stage III
Affiliated Hospitals
Clinical Trials Neeta Pandit-Taskar, MD is currently running
Peptide Receptor Radionuclide Therapy
for Neuroblastoma
This trial is testing a new treatment called 67Cu-SARTATE for children with high-risk neuroblastoma. The treatment uses radiation to target and kill cancer cells. The goal is to see if this approach is safe and effective for these patients.
Recruiting1 award Phase 1 & 211 criteria
Radioactive MIBG
for Neuroblastoma
The purpose of this research study is to find how active and safe 131 I-MIBG is in patients with resistant neuroblastoma, malignant pheochromocytoma and malignant paraganglioma.
Recruiting1 award Phase 210 criteria
More about Neeta Pandit-Taskar, MD
Clinical Trial Related4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Neeta Pandit-Taskar, MD has experience with
- Iodine-124 Labeled Humanized A33
- 89Zr-DFO-HuMab-5B1
- 124IcG250
- Iobenguane I 131
- 18F-MFBG
- Positron Emission Tomography (PET) Imaging
Breakdown of trials Neeta Pandit-Taskar, MD has run
Renal Cell Carcinoma
Pancreatic Cancer
Thyroid Cancer
Kidney Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Neeta Pandit-Taskar, MD specialize in?
Neeta Pandit-Taskar, MD focuses on Renal Cell Carcinoma and Pancreatic Cancer. In particular, much of their work with Renal Cell Carcinoma has involved Stage IV patients, or patients who are KRAS positive.
Is Neeta Pandit-Taskar, MD currently recruiting for clinical trials?
Yes, Neeta Pandit-Taskar, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Neeta Pandit-Taskar, MD has studied deeply?
Yes, Neeta Pandit-Taskar, MD has studied treatments such as Iodine-124 labeled humanized A33, 89Zr-DFO-HuMab-5B1, 124IcG250.
What is the best way to schedule an appointment with Neeta Pandit-Taskar, MD?
Apply for one of the trials that Neeta Pandit-Taskar, MD is conducting.
What is the office address of Neeta Pandit-Taskar, MD?
The office of Neeta Pandit-Taskar, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.